These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 38305336

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.
    Ai Y, Liu S, Luo H, Wu S, Wei H, Tang Z, Li X, Lv X, Zou C.
    J Immunol Res; 2021; 2021():6149558. PubMed ID: 34476262
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m6A Methylation in Oral Squamous Cell Carcinoma.
    Liu L, Wu Y, Li Q, Liang J, He Q, Zhao L, Chen J, Cheng M, Huang Z, Ren H, Chen J, Peng L, Gao F, Chen D, Wang A.
    Mol Ther; 2020 Oct 07; 28(10):2177-2190. PubMed ID: 32621798
    [Abstract] [Full Text] [Related]

  • 6. METTL14 inhibits malignant progression of oral squamous cell carcinoma by targeting the autophagy-related gene RB1CC1 in an m6A-IGF2BP2-dependent manner.
    Liang J, Cai H, Hou C, Song F, Jiang Y, Wang Z, Qiu D, Zhu Y, Wang F, Yu D, Hou J.
    Clin Sci (Lond); 2023 Sep 13; 137(17):1373-1389. PubMed ID: 37615536
    [Abstract] [Full Text] [Related]

  • 7. KIAA1429 promotes the malignancy of oral squamous cell carcinoma by regulating CA9 m6A methylation.
    Tu J, Feng X, Cao Q, Guan Y.
    Cytotechnology; 2024 Oct 13; 76(5):585-594. PubMed ID: 39188646
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of methyltransferase-like 3 and 14 in oral squamous cell carcinoma.
    Wu S, Makeudom A, Sun X, Li X, Xu D, Sastraruji T, Lumbikananda N, Buranaphatthana W, Krisanaprakornkit S.
    J Oral Pathol Med; 2022 Feb 13; 51(2):134-145. PubMed ID: 34689367
    [Abstract] [Full Text] [Related]

  • 9. Inhibin A contributes to the tumorigenesis of oral squamous cell carcinoma by KIAA1429-mediated m6A modification.
    Chen X, Fan R.
    J Oral Pathol Med; 2024 Apr 13; 53(4):266-274. PubMed ID: 38531807
    [Abstract] [Full Text] [Related]

  • 10. Fat mass and obesity-associated protein regulates tumorigenesis of arecoline-promoted human oral carcinoma.
    Li X, Xie X, Gu Y, Zhang J, Song J, Cheng X, Gao Y, Ai Y.
    Cancer Med; 2021 Sep 13; 10(18):6402-6415. PubMed ID: 34378866
    [Abstract] [Full Text] [Related]

  • 11. HNRNPA2B1 promotes oral squamous cell carcinogenesis via m6A-dependent stabilization of FOXQ1 mRNA stability.
    Wang X, Zhi M, Zhao W, Deng J.
    IUBMB Life; 2024 Jul 13; 76(7):437-450. PubMed ID: 38265150
    [Abstract] [Full Text] [Related]

  • 12. SALL4 promotes cancer stem-like cell phenotype and radioresistance in oral squamous cell carcinomas via methyltransferase-like 3-mediated m6A modification.
    Huang J, Li H, Yang Z, Liu R, Li Y, Hu Y, Zhao S, Gao X, Yang X, Wei J.
    Cell Death Dis; 2024 Feb 14; 15(2):139. PubMed ID: 38355684
    [Abstract] [Full Text] [Related]

  • 13. Oxymatrine suppresses oral squamous cell carcinoma progression by suppressing CXC chemokine receptor 4 in an m6A modification decrease dependent manner.
    Luo R, Xie L, Lin Y, Shao J, Lin Z.
    Oncol Rep; 2022 Oct 14; 48(4):. PubMed ID: 36004481
    [Abstract] [Full Text] [Related]

  • 14. Effects of Allocryptopine on the Proliferation and Epithelial-Mesenchymal Transition of Oral Squamous Cell Carcinoma through m6A Mediated Hedgehog Signaling Pathway.
    Gong J, Wang C, Zhang F, Lan W.
    J Environ Pathol Toxicol Oncol; 2022 Oct 14; 41(2):15-24. PubMed ID: 35695648
    [Abstract] [Full Text] [Related]

  • 15. m6A methyltransferase METTL3 promotes oral squamous cell carcinoma progression through enhancement of IGF2BP2-mediated SLC7A11 mRNA stability.
    Xu L, Li Q, Wang Y, Wang L, Guo Y, Yang R, Zhao N, Ge N, Wang Y, Guo C.
    Am J Cancer Res; 2021 Oct 14; 11(11):5282-5298. PubMed ID: 34873461
    [Abstract] [Full Text] [Related]

  • 16. METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m6A Modification.
    Zhao W, Cui Y, Liu L, Ma X, Qi X, Wang Y, Liu Z, Ma S, Liu J, Wu J.
    Mol Ther Nucleic Acids; 2020 Jun 05; 20():1-12. PubMed ID: 32145676
    [Abstract] [Full Text] [Related]

  • 17. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
    Chen M, Wei L, Law CT, Tsang FH, Shen J, Cheng CL, Tsang LH, Ho DW, Chiu DK, Lee JM, Wong CC, Ng IO, Wong CM.
    Hepatology; 2018 Jun 05; 67(6):2254-2270. PubMed ID: 29171881
    [Abstract] [Full Text] [Related]

  • 18. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
    Zhang HM, Qi FF, Wang J, Duan YY, Zhao LL, Wang YD, Zhang TC, Liao XH.
    Int J Mol Sci; 2022 Jun 09; 23(12):. PubMed ID: 35742899
    [Abstract] [Full Text] [Related]

  • 19. M6A-related bioinformatics analysis reveals that HNRNPC facilitates progression of OSCC via EMT.
    Huang GZ, Wu QQ, Zheng ZN, Shao TR, Chen YC, Zeng WS, Lv XZ.
    Aging (Albany NY); 2020 Jun 11; 12(12):11667-11684. PubMed ID: 32526707
    [Abstract] [Full Text] [Related]

  • 20. Long noncoding RNA lnc-H2AFV-1 promotes cell growth by regulating aberrant m6A RNA modification in head and neck squamous cell carcinoma.
    Chen X, Liu Y, Sun D, Sun R, Wang X, Li M, Song N, Ying J, Guo T, Jiang Y.
    Cancer Sci; 2022 Jun 11; 113(6):2071-2084. PubMed ID: 35403343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.